T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Warby Parker
WRBY
$3.13B
| $674M | 0.07% |
19,949,381
+430,661
| +2% | +$13.9M |
|
277
IDEX
IEX
$17.7B
| $673M | 0.07% |
3,510,395
-279,739
| -7% | -$56.7M |
|
|
SRCL
278
DELISTED
Stericycle Inc
SRCL
| $672M | 0.07% |
11,398,057
+335,238
| +3% | +$19.4M |
|
|
CTXS
279
DELISTED
Citrix Systems Inc
CTXS
| $663M | 0.07% |
6,566,881
-10,537,916
| -62% | -$1.06B |
|
280
GSK
GSK
$101B
| $662M | 0.07% |
12,149,902
+53,743
| +0.4% | +$2.92M |
|
281
Doximity
DOCS
$4.45B
| $660M | 0.07% |
12,671,287
-2,306,587
| -15% | -$116M |
|
282
Domino's
DPZ
$11.7B
| $655M | 0.07% |
1,608,854
+331,258
| +26% | +$144M |
|
283
Broadridge
BR
$19.3B
| $653M | 0.07% |
4,196,639
+242,882
| +6% | +$37.3M |
|
|
P
284
Everpure Inc
P
$37B
| $647M | 0.07% |
18,321,760
+3,504,500
| +24% | +$102M |
|
285
Amgen
AMGN
$225B
| $644M | 0.06% |
2,662,941
-5,595
| -0.2% | -$1.29M |
|
286
AXIS Capital
AXS
$7.26B
| $643M | 0.06% |
10,634,240
-24,502
| -0.2% | -$1.37M |
|
287
Yum China
YUMC
$16.4B
| $642M | 0.06% |
15,446,199
+2,046,947
| +15% | +$96.4M |
|
288
Nutrien
NTR
$32.1B
| $639M | 0.06% |
+6,143,560
| New | +$509M |
|
289
FirstService
FSV
$6.24B
| $638M | 0.06% |
4,401,140
-587,608
| -12% | -$89.4M |
|
290
Cummins
CMI
$87.8B
| $629M | 0.06% |
3,065,159
+426,274
| +16% | +$92.2M |
|
291
Magna International
MGA
$18.6B
| $620M | 0.06% |
9,647,264
-219,458
| -2% | -$16.3M |
|
292
Regeneron Pharmaceuticals
REGN
$82.2B
| $615M | 0.06% |
880,341
-32,914
| -4% | -$20.8M |
|
293
Canadian Pacific Kansas City
CP
$81.5B
| $610M | 0.06% |
7,387,461
+1,382,538
| +23% | +$104M |
|
294
Public Storage
PSA
$60.4B
| $610M | 0.06% |
1,562,188
+612,447
| +64% | +$222M |
|
|
TMX
295
DELISTED
Terminix Global Holdings, Inc.
TMX
| $606M | 0.06% |
13,287,472
-102,900
| -0.8% | -$4.44M |
|
296
ICU Medical
ICUI
$4.48B
| $603M | 0.06% |
2,707,841
-17,699
| -0.6% | -$3.96M |
|
297
Huazhu Hotels Group
HTHT
$12.7B
| $590M | 0.06% |
17,884,001
-1,192,824
| -6% | -$44.2M |
|
298
Corteva
CTVA
$50.4B
| $587M | 0.06% |
10,209,096
+1,571,444
| +18% | +$80.3M |
|
299
Mercado Libre
MELI
$92.7B
| $586M | 0.06% |
492,483
+21,019
| +4% | +$22.9M |
|
300
Idexx Laboratories
IDXX
$45B
| $585M | 0.06% |
1,069,261
+370,413
| +53% | +$195M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.